The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older adults after a benefit-risk reevaluation, though the move comes with an ...

The US Department of Health and Human Services (HHS) has terminated 22 messenger RNA vaccine research projects, totalling ...

Cases of chikungunya—a virus that spreads through mosquito bites—are surging in Mumbai, showing an upward trend. According to data from BMC’s Epidemiology and Public Health Department Cell, a total of ...

Such is the position of Professor Russell Stewart ( pictured ), who lost his job after his opposition to Minnesota Gov. Tim ...

Ever since RFK Jr has taken over HHS, a lot has changed. Whether it is about US pulling out of global health funding or ...

Public-health leaders have responded with horror and disbelief. “Robert F. Kennedy junior is not remotely qualified for the ...

Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

Health and Human Services Secretary Robert F. Kennedy Jr. accepted a vote by a federal immunization panel to recommend the ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

Access is the central tenet to the success of lenacapavir as a form of preexposure prophylaxis (PrEP), according to Jeremiah Johnson, the executive director of PrEP4All and Mitchell Warren, the ...

The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...